Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Del Laboratories was a prominent American manufacturer and marketer of cosmetics and over-the-counter (OTC) pharmaceutical products. The company was widely recognized for its market-leading brands, including Sally Hansen in the nail care category and Orajel for oral pain relief. Founded in 1961, it operated as a public entity for several decades before being taken private by Kelso & Company in 2004. In 2007, the company was acquired by Coty Inc. for approximately $800 million, marking a significant consolidation in the beauty and personal care industry. Following the acquisition, the pharmaceutical division was divested to Church & Dwight, while the beauty assets were integrated into Coty's global portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Del Laboratories.